Skip to content

Study to compare the effect of Gandiradi Taila and Jatyadi Taila in the treatment of Dushta vrana in diabetic foot ulcer patients

Randomised Comparative Study of Gandiradi Taila and Jatyadi Taila in The Management of Dushta Vrana (Diabetic foot Ulcer) - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105536
Enrollment
60
Registered
2026-03-06
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications

Interventions

None listed

Sponsors

Vd Vatsal Sunil Jawanjal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Individuals presenting with a diagnosis of Dushta Vrana (Diabetic foot ulcer) with signs and symptoms of Dushta Vrana as per Sushruta Samhita. 1. Patients of age group between 30-70 years. 2. Patients will be included regardless of their socioeconomic status, financial background, or gender. 3. Patient with Dushta Vrana associated with controlled diabetes mellitus. 4. Patient with Dushta Vrana with a maximum history of 8 months. 5. Dushta Vrana of size 3-8 cm in length and width.

Exclusion criteria

Exclusion criteria: 1. Individuals with a diagnosis of Tuberculosis, Sepsis, Neurological conditions, or vascular diseases. 2. Patients presenting with trophic ulcers or ulcers resulting from animal bites. 3. Those with pre-existing bleeding disorders. 4. Individuals younger than 30 years or older than 70 years of age. 5. Patients with a confirmed diagnosis of Anaemia. 6. The presence of cancerous (carcinomatous) lesions. 7. Wounds resulting from burns (Dagdha Vrana). 8. Patients with sexually transmitted diseases (STDs). 9. Pregnant women.

Design outcomes

Primary

MeasureTime frame
To evaluate efficacy of Gandiradi Taila and Jatyadi Taila in the Management of Dushta Vrana (Diabetic foot)Timepoint: 28 Days

Secondary

MeasureTime frame
Reduction in wound size Reduction in Discharge/Slough Pain reductionTimepoint: 28 Days

Countries

India

Contacts

Public ContactVd Vatsal Sunil Jawanjal

Ashvin Rural Ayurved College And Hospital Manchi Hill Sangamner

vvtamhane@gmail.com9764139607

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026